Urinary prostaglandin E2 was increased in patients with suprapontine brain diseases, and associated with overactive bladder syndrome

Urology

Volumn 76, Issue 5, 2010, Pages 1267.e13-1267.e19

  Yamauchi, Hiroki ^a   Akino, Hironobu ^a   Ito, Hideaki ^a   Aoki, Yoshitaka ^a   Nomura, Tadao ^b   Yokoyama, Osamu ^a  

^a UNIVERSITY OF FUKUI   (Japan)

^b Toyama Koshi Rehabilitation Hospital   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CREATININE; NERVE GROWTH FACTOR; PROSTAGLANDIN E2; PROSTAGLANDIN F2 ALPHA; SUBSTANCE P;

ADULT; AGED; ARTICLE; BRAIN DISEASE; CONTROLLED STUDY; CREATININE URINE LEVEL; DISEASE ASSOCIATION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; LOWER URINARY TRACT SYMPTOM; MAJOR CLINICAL STUDY; MALE; OVERACTIVE BLADDER; POSTVOID RESIDUAL URINE VOLUME; PRIORITY JOURNAL; SUPRAPONTINE BRAIN DISEASE;

EID: 78149360768     PISSN: 00904295     EISSN: 15279995     Source Type: Journal    
DOI: 10.1016/j.urology.2010.06.012     Document Type: Article

References (25)

1. P. Abrams, L. Cardozo, and M. Fall The standardization of terminology of lower urinary tract function: report from the Standardization Sub-Committee of the International Continence Society Neurourol Urodyn 21 2002 167 178
2. J.C. Kim, E.Y. Park, S.H. Hong, S.I. Seo, Y.H. Park, and T.K. Hwang Changes of urinary nerve growth factor and prostaglandins in male patients with overactive bladder symptom Int J Urol 12 10 2005 875 880
3. H.T. Liu, and H.C. Kuo Urinary nerve growth factor level could be a potential biomarker for diagnosis of overactive bladder J Urol 179 2008 2270 2274
4. O. Yokoyama, K. Komatsu, and Y. Ishiura Change in bladder contractility associated with bladder overactivity in rats with cerebral infarction J Urol 159 2 1998 577 580
5. E.E. Ustinova, D.W. Gutkin, and M.A. Pezzone Sensitization of pelvic nerve afferents and mast cell infiltration in the urinary bladder following chronic colonic irritation is mediated by neuropeptides Am J Physiol Ren Physiol 292 1 2007 F123 F130
6. Y. Homma, M. Yoshida, and N. Seki Symptom assessment tool for overactive bladder syndromeoveractive bladder symptom score Urology 68 2 2006 318 323
7. W.D. Steers, S. Kolbeck, D. Creedon, and J.B. Tuttle Nerve growth factor in the urinary bladder of the adult regulates neuronal form and function J Clin Invest 88 5 1991 1709 1715
8. J.C. Kim, D.B. Kim, S.I. Seo, Y.H. Park, and T.K. Hwang Nerve growth factor and vanilloid receptor expression, and detrusor instability, after relieving bladder outlet obstruction in rats BJU Int 94 6 2004 915 918
9. N. Yoshimura, N.E. Bennett, and Y. Hayashi Bladder overactivity and hyperexcitability of bladder afferent neurons after intrathecal delivery of nerve growth factor in rats J Neurosci 26 42 2006 10847 10855
10. T. Yokoyama, H. Kumon, and A. Nagai Correlation of urinary nerve growth factor level with pathogenesis of overactive bladder Neurourol Urodyn 27 5 2008 417 420
11. W.D. Steers Pathophysiology of overactive bladder and urge urinary incontinence Rev Urol 4 Suppl 4 2002 S7 S18
12. L.A. Birder, A. Wolf-Johnston, D. Griffiths, and N.M. Resnick Role of urothelial nerve growth factor in human bladder function Neurourol Urodyn 26 3 2007 405 409
13. H.T. Liu, M.B. Chancellor, and H.C. Kuo Urinary nerve growth factor levels are elevated in patients with detrusor overactivity and decreased in responders to detrusor botulinum toxin-A injection Eur Urol 56 2008 700 706
14. F. Cruz, and P. Dinis Resiniferatoxin and botulinum toxin type A for treatment of lower urinary tract symptoms Neurourol Urodyn 26 Suppl 2007 920 927 (6)
15. H.T. Liu, A.B. Liu, M.B. Chancellor, and H.C. Kuo Urinary nerve growth factor level is correlated with the severity of neurological impairment in patients with cerebrovascular accident BJU Int 104 8 2009 1158 1162
16. M.A. Khan, C.S. Thompson, and F.H. Mumtaz Role of prostaglandins in the urinary bladder: an update Prostaglandins Leukot Essent Fatty Acids 596 1998 415 422
17. D.O. Stichtenoth, V. Marhauer, D. Tsikas, F.M. Gutzki, and J.C. Frolich Effects of specific cox-2-inhibition on renin release and renal and systemic prostanoid synthesis in healthy volunteers Kidney Int 68 5 2005 2197 2207
18. R.C. Harris Interactions between cox-2 and the renin-angiotensin system in the kidney Acta Physiol Scand 177 4 2003 423 427
19. K.E. Andersson LUTS treatment: future treatment options Neurourol Urodyn 26 Suppl 2007 934 947 (6)
20. C.A. Maggi Prostanoids as local modulators of reflex micturition Pharmacol Res 25 1 1992 13 20
21. G.P. McCafferty, B.A. Misajet, N.J. Laping, R.M. Edwards, and K.S. Thorneloe Enhanced bladder capacity and reduced prostaglandin E2-mediated bladder hyperactivity in EP3 receptor knockout mice Am J Physiol Ren Physiol 295 2 2008 F507 F514
22. D.F. Pratico (2)-isoprostanes: sensitive and specific non-invasive indices of lipid peroxidation in vivo Atherosclerosis 147 1 1999 1 10
23. J.M. Masick, R.M. Levin, and M.A. Hass The effect of partial outlet obstruction on prostaglandin generation in the rabbit urinary bladder Prostaglandins Other Lipid Mediat 66 3 2001 211 219
24. A. Sukiennik, D.B. Carr, and I. Bonney The effect of short-term epidural local anesthetic blockade on urinary levels of substance P in interstitial cystitis Anesth Analg 98 3 2004 846 850
25. K.M. Azadzoi, Z.M. Radisavljevic, T. Golabek, S.V. Yalla, and M.B. Siroky Oxidative modification of mitochondrial integrity and nerve fiber density in the ischemic overactive bladder J Urol 183 1 2010 362 369